QRX
Click for more information
0.00% 2.8¢ qrxpharma ltd

The reason for the weakness maybe due to a fast diminishing cash...

  1. toafk
    7 Posts.
    clock Created with Sketch.
    17/10/13
    11:36
    Post #: 12451577
    The reason for the weakness maybe due to a fast diminishing cash position. They do not have enough cash to get through to FDA approval next May. The market is probably anticipating a capital raising
    QRX Price at posting: 66.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add QRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.